Research, explained.

Beta-alanine did not clearly improve repeated sprint ability compared with placebo. The pooled results were nonsignificant for average performance, peak performance and fatigue decrement, meaning the fall in performance across sprints. These findings do not prove there is no effect, and they apply to repeated sprinting rather than exercise performance in general.

Keep in mind: The abstract does not provide individual protocols or evidence-certainty ratings. This abstract-based account cannot fully assess confidence in the pooled results.

Nightly lavender aromatherapy and virtual reality were followed by better questionnaire-based sleep quality than routine care in this short trial of people with type 2 diabetes. The findings suggest a brief improvement in perceived sleep. They do not show lasting benefits, establish that either approach is superior, or demonstrate improved diabetes control.

Keep in mind: This abstract-based account describes a short study at a single center. It cannot establish durability, and the abstract gives no details about how blinding was achieved for these different interventions.

The review describes links among physical activity, sleep, mental health and athletic recovery. It reports that sleep loss can impair performance and that adequate or extended sleep is associated with better recovery. Because this is a narrative synthesis of varied evidence, it does not provide a single tested routine or a precise expected benefit.

Keep in mind: This abstract-based account lacks study counts, pooled estimates and a detailed quality appraisal. The review mixes trials, observational studies and expert statements, so its broad conclusions do not all carry the same evidential weight.

Interventions involving awareness of internal body signals were associated with improvements in some eating-disorder behaviors and emotional regulation. Mindfulness approaches were studied most often, while evidence for exposure-based methods and biofeedback was preliminary. High risk of bias across much of the evidence means these findings cannot establish how reliably the approaches improve eating-disorder symptoms.

Keep in mind: Most studies had a high risk of bias, and measures of internal body awareness were not standardized. This abstract-based account also lacks comparator details, follow-up lengths and numerical estimates of symptom change.

After the intervention, the betaine-containing nutrient group had greater improvements in homocysteine, several blood sugar and lipid measures, and selected body measurements than the vitamin comparison group. Both groups improved on multiple outcomes. These findings concern people with excess weight and elevated homocysteine; they do not establish reduced cardiovascular disease or benefits for the general population.

Keep in mind: The abstract does not specify the nutrient formulation, doses or absolute between-group changes. This abstract-based account therefore cannot isolate betaine's contribution or judge the clinical importance of the reported statistical differences.

Children receiving phosphatidylserine did not show statistically significant improvement in core ADHD symptoms. The group did show reductions in internalizing and externalizing behavioral problems, including aggression. These results separate broader behavior changes from ADHD symptom control, and the abstract's group-specific significance tests do not establish that the supplement is better or worse than atomoxetine.

Keep in mind: The trial was open-label and small. This abstract-based account lacks direct between-group effect estimates; differences in which results reached statistical significance cannot establish comparative effectiveness. The abstract also does not report longer follow-up.

In this pilot trial, the lower-dose creatine arm showed a greater improvement in fatigue scores than placebo, alongside a handgrip-strength improvement. Everyone also took part in physical activity. The abstract does not give corresponding outcome estimates for the higher-dose arm, so it cannot establish which dose performed better or whether benefits persist.

Keep in mind: This abstract-based summary covers a short pilot trial with incomplete follow-up. Results for the higher-dose arm are not detailed, and minimal, temporary adverse events do not establish long-term safety.

Uneven strength between hands was associated with higher mortality from any cause and from cardiovascular disease. Compared with imbalance alone, imbalance alongside low strength showed a stronger association with deaths from any cause. These observational findings suggest a possible risk marker; they do not show that imbalance causes death or that correcting it improves survival.

Keep in mind: This abstract-based account lacks follow-up lengths, definitions of grip asymmetry, reference-group details and adjustment methods. Those omissions limit interpretation of the pooled associations and prevent estimating an individual's absolute probability of death.

Restricting daily eating to a set window was linked to modest weight loss compared with eating freely, but the review found no consistent benefit over calorie restriction. Blood pressure showed the most consistent improvement. Blood sugar, insulin sensitivity and blood fats changed little or inconsistently, leaving the overall clinical value uncertain.

Keep in mind: The abstract does not give study counts, participant characteristics, follow-up lengths or uncertainty estimates for its summary findings. It also calls for larger, longer studies measuring clinically relevant outcomes.

The review describes potential roles for anabolic medicines and nutritional supplements in rebuilding muscle after critical illness. Evidence differs across treatments and patient groups: oxandrolone has the strongest clinical support, particularly after burns, while testosterone findings are still emerging. The authors place these approaches within nutrition and rehabilitation programmes and call for further trials.

Keep in mind: The abstract provides no study counts, treatment comparisons, effect sizes or detailed safety results. It cannot establish how much any individual therapy improves recovery or which patients benefit.

Polypills were associated with fewer major adverse cardiovascular events in secondary prevention, aimed at preventing further events. The main analysis found no statistically clear reduction in primary prevention, aimed at preventing a first event, or mixed populations. Results also depended on which combined-event outcome was analyzed, and several individual outcomes showed no clear improvement.

Keep in mind: The evidence includes randomized and observational studies. This abstract-based account cannot resolve unreported follow-up duration or the unexplained distinction between the combined-event outcomes.

This review mapped how nursing research has addressed anxiety, sleep quality and well-being. Sleep was the most studied outcome, especially through changes to the hospital environment. The abstract describes a wide range of approaches but gives no effect estimates, so it cannot show which strategy works best or whether the approaches have comparable benefits.

Keep in mind: This is an abstract-based account of a scoping review, which maps a research field. The abstract supplies no intervention-specific effects or safety results, and many included clinical trials came from Iran and Turkey.

Inositol supplementation was associated with lower testosterone and related measures of excess androgen activity in women with PCOS. Results varied substantially across studies. The clearest subgroup signal appeared in women of normal weight, but those analyses were exploratory. The abstract does not establish improvements in unwanted hair growth, ovulation or patients' day-to-day experience.

Keep in mind: Treatment comparators and durations are not described in the abstract. Substantial variation between studies and exploratory subgroup analyses limit confidence in how the findings apply to individual patients.

Both light-treatment groups improved sensitive-skin questionnaire scores compared with the emollient-only control. Sting-test scores also improved in both groups, while yellow light improved additional skin measurements. The abstract reports statistical significance but not the size of symptom changes, and it does not provide a direct comparison establishing that either light treatment is superior.

Keep in mind: The trial was small and conducted at a single centre. The abstract does not report blinding or symptom-effect sizes, and the limited observation period cannot establish longer-term safety.

Exercise-based prevention programmes lowered hamstring injury risk on average compared with usual practice or warm-up. However, the evidence was rated low certainty, and results varied enough that a future setting might not show benefit. Better adherence was associated with stronger effects; the analysis cannot establish that adherence alone caused those differences.

Keep in mind: The abstract rates the evidence as low certainty. Its prediction interval allows no benefit in a new setting, and the review could not distinguish programme types or components.

The review discusses whether metformin could influence biological aging through several cellular pathways. It also describes human evidence linking use with lower mortality and fewer age-related diseases, alongside potentially adverse findings in aged animals. These mixed sources do not, as summarized in the abstract, establish that metformin slows aging or extends life in otherwise healthy people.

Keep in mind: The abstract provides no study-level comparisons, effect estimates or follow-up durations. Human associations cannot establish causation, and the randomized evidence is mentioned without enough detail to assess its contribution.

Early eating produced mixed results across clinical subgroups. Diastolic blood pressure, the lower reading, decreased in adults with hypertension, and a blood sugar marker improved in those with prediabetes. Cholesterol rose in adults with severe obesity. These exploratory findings concern adults receiving weight-loss treatment and do not establish a benefit for everyone.

Keep in mind: The abstract does not define the uncertainty measures accompanying these estimates. This was an exploratory subgroup analysis, and the small Black participant sample limits interpretation of apparent racial differences.

Active tDCS lowered depressive symptom scores immediately after treatment compared with sham in people with treatment-resistant depression. The smaller follow-up evidence set found no statistically significant difference. That leaves lasting benefit uncertain and does not establish equivalence. Results varied substantially across trials, so the pooled immediate improvement should be interpreted cautiously.

Keep in mind: The review drew on a few small trials with inconsistent findings. The abstract provides no detailed safety results and does not identify the type or confidence level of the reported intervals.

The combination showed a greater reduction in morning blood pressure measured at home, while clinic measurements fell in both groups. Some blood fat and insulin-related markers also improved, but fasting glucose, HbA1c and quality-of-life scores did not change. These results concern a combined supplement and measured risk markers, rather than demonstrated prevention of cardiovascular events.

Keep in mind: The abstract does not clearly separate changes within the supplement group from differences versus placebo for most markers. The combination design cannot identify the separate contribution of either ingredient.

The higher vitamin D dose did not show superior improvement in depressive symptoms when added to existing treatment. The estimated difference was small, and its confidence interval included no difference. This result does not prove the doses are equivalent or establish whether either dose helps compared with taking no vitamin D.

Keep in mind: This abstract-based brief cannot explain why some participants lacked outcome data. Because both groups received vitamin D, the trial also cannot establish a benefit compared with no supplementation.

The trial reported lower levels of several inflammatory proteins after composite polyphenols, alongside exploratory changes in gut bacteria and blood metabolites. This is evidence about biological markers in a short trial. It does not establish that the supplement removes microplastics, prevents disease, or improves how participants feel or function.

Keep in mind: The abstract does not report the supplement's composition or dose, whether fecal microplastic concentrations changed with treatment, or patient health outcomes. Blood-marker changes alone cannot establish protection from microplastic-related illness.

Adults with higher Mediterranean diet adherence scores had lower all-cause mortality in the pooled cohort evidence. The estimate compares scores and does not test switching to a particular menu. Because the included studies were observational, the analysis cannot establish that changing diet would produce the same mortality difference for an individual.

Keep in mind: This abstract-based explanation draws on observational studies with widely varying follow-up. The abstract does not explain how increments on different validated diet scores were made comparable.

Across the included randomized trials, honey dressings were associated with higher odds of complete ulcer healing than conventional dressings. The evidence for this outcome was rated moderate. Healing also appeared faster, but that evidence was rated low. The abstract supports a cautious comparison of wound dressings, without establishing a universal treatment choice.

Keep in mind: The abstract does not give units for the healing-time estimate or present adverse-event results, despite concluding that honey dressings are safe. It also does not describe the specific dressings or wound-care procedures used.

The study reported lower pain ratings, systolic blood pressure and heart rate with music during postoperative bedside care, alongside a higher pressure pain threshold. These findings concern an immediate care setting after orthopedic surgery. The abstract does not show how large the changes were or whether they persisted beyond the procedure.

Keep in mind: Results are given as significance tests without effect sizes or confidence intervals. The abstract describes before-and-after assessments but does not clearly identify the statistical contrast for each result, limiting interpretation of the difference between randomized groups.